Japan Insertable Cardiac Monitors (ICM) Market

Japan Insertable Cardiac Monitors (ICM) Market Summary:

According to Transpire Insight, a detailed research report on the Japan Insertable Cardiac Monitors (ICM) Market reflects that the market was valued at approximately USD 87.8 million in 2025 and is expected to reach USD 98.2 million in 2026, with the market projected to reach approximately USD 161.8 million by 2033, registering a forecast CAGR of 7.39% during 2026–2033, making it a significant contributor to Japan’s cardiac monitoring market development, medical technology innovation, advanced insertable cardiac monitoring solutions, expanding healthcare capabilities, and overall market growth dynamics.

Market Snapshot

• Market Value (2025): USD 87.8 Million.
• Expected Market Value (2026): USD 98.2 Million.
• Estimated Market Value (2033): USD 161.8 Million.
• Forecast CAGR (2026–2033): 7.39%.

Introduction

The Japan Insertable Cardiac Monitor (ICM) market is a significant segment of Japan’s cardiac diagnostics market as physicians continue to struggle with the clinical challenge of diagnosing hard-to-diagnose cardiac arrhythmias. These small, leadless devices are implanted just beneath the skin of the chest and, unlike traditional electrocardiograms or short-term Holter monitors, enable long-term, continuous tracking of cardiac electrical activity. Continuous surveillance is essential for the diagnosis of unexplained syncope, cryptogenic stroke and silent atrial fibrillation which are frequently missed using intermittent testing modalities. As Japan’s healthcare system evolves toward precision diagnostics and remote patient management, the critical importance of the ICM market in enabling early arrhythmia detection, timely clinical intervention and improved patient outcomes is now more essential than ever in cardiology practices across the country.

Key Market Highlights: -

• By Product Type, the Implantable Loop Recorders dominated the market and holds approximately 50% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
• By Indication, the ATRIAL FIBRILLATION dominated the market and holds approximately 41.8 share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
• By Technology, the Continuous Monitoring Manufacturers segment dominated the market and holds approximately 60.16 share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
• Technological Advancement: The Japanese ICM market offers ultra-miniaturized, MRI-conditional monitors with long, multi-year battery life, allowing for continuous, uninterrupted cardiac rhythm monitoring with decreased patient discomfort and frequency of clinical intervention.

How is Technology Driving Growth in the Japan Insertable Cardiac Monitors (ICM) Market?

Technology is the basic driver of growth in the Insertable Cardiac Monitors (ICM) market in Japan and is growing fast with continuous innovation in four major dimensions. The miniaturisation of devices has revolutionised the device design allowing for minimally invasive insertions with incision sizes less than 1cm and improving comfort for elderly patients. Now algorithms using artificial intelligence filter out false alarms, giving cardiologists cleaner high-confidence data to make a diagnosis. Moreover, wireless remote patient monitoring enables automatic transfer of data to hospital networks on a daily basis, thus avoiding unnecessary visits to clinics. Moreover, MR conditional compatibility removes a long-term barrier for patients requiring to undergo an MRI scan, thus making technological advancement the key growth driver in this market.

Market Drivers

Japan insertable cardiac monitor (ICM) market is witnessing strong growth due to three interlinked growth drivers. First, the country’s super-aged population (more than 29% of its citizens are 65 and older) is driving a rapid increase in cardiovascular diseases such as atrial fibrillation and unexplained syncope. Second, advanced remote patient monitoring infrastructure allows for the real-time, wireless transmission of data, thus linking rural patients with specialised electrophysiologists in urban centers. Third, the incorporation of AI-based rhythm detection algorithms is enhancing diagnostic accuracy and significantly lowering false-positive readings, thus bolstering clinical confidence and accelerating wider acceptance throughout Japan’s healthcare system.

Restrain

“ICM market in Japan has very strong growth potential but also faces significant headwinds. Strict reimbursement frameworks and narrow clinical indication guidelines limit adoptability compared with Western markets, and high device and procedural costs stretch hospital procurement budgets. The complex regulatory approval pathways via MHLW and the complex implantation protocols also slow down the market penetration. In addition, the lack of specialists trained in remote monitoring and continuing concerns regarding data security and device maintenance continue to serve as a barrier to wider adoption in smaller healthcare facilities.

Analysis of Prices and Consumer Behaviour

The Japan Insertable Cardiac Monitors market is characterized by the prevalence of sophisticated implantable cardiac monitors owing to the increasing requirement for continuous and extended monitoring of intermittent cardiac ailments including arrhythmias, unexplained syncope, atrial fibrillation and other such ailments. The market was assessed to be worth USD 87.8 million in 2025 and is estimated to reach USD 98.2 million in 2026 whereas the market is further expected to reach USD 161.8 million in 2033 registering a forecast CAGR of 7.39% in 2026-2033. The increased demand for the ICM systems is backed up by the fact that these systems offer continuous cardiac monitoring which is minimally invasive, helps to increase the accuracy of diagnosis and timely intervention as well. Nearly 45% of ICM units are adopted for small-sized and long-duration implantable monitoring systems owing to the benefits offered by these devices in the form of continuous monitoring, long device life as well as compatibility of these devices with patients in need of long-term cardiac rhythm monitoring. Purchasing Behavior of Healthcare Providers. It has been observed that 55% of the purchasing behavior of the healthcare providers is based on the significance of accurate monitoring and the reliability of the medical devices along with their battery life as well as arrhythmia detection features. Moreover, another 33% of healthcare providers or institutional purchasers like to purchase the cardiac monitoring devices through bulk purchasing or long-term contracts because they want to save the cost of procurement of these devices.

Top Companies in the Japan Insertable Cardiac Monitors (ICM) Market

1. Medtronic
2. Abbott
3. Boston Scientific
4. BIOTRONIK
5. MicroPort
6. Nihon Kohden
7. Fukuda Denshi
8. Japan Lifeline
9. Terumo
10. Edwards Lifesciences
11. Philips
12. GE HealthCare
13. Siemens Healthineers
14. LivaNova
15. Koninklijke KPN

Japan Insertable Cardiac Monitors (ICM) Market Segmentation

The Japan Insertable Cardiac Monitors (ICM) Market share is divided into six categories: By Product Type, By Indication, By Technology, By Implant Location, By End User, By Patient Group.

The Implantable Loop Recorders dominated the market, accounting for nearly 50% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The Japan Insertable Cardiac Monitors (ICM) Market is segmented by product type into insertable cardiac monitors, implantable loop recorders, remote monitoring systems, patient-activated monitors, auto-triggered monitors, mri-compatible icms, long-term monitoring devices, connected icms. Among these, the Implantable Loop Recorders segment dominated the market, accounting for nearly 50% in 2025 and expected to increase at a significant CAGR during the forecast period. Superior diagnostic accuracy, multi-year battery life and minimally invasive insertion continued to drive clinician and patient preference.

The Atrial Fibrillation dominated the market, accounting for nearly 41.8 in 2025, and is expected to rise at a significant CAGR during the forecast period.

The Japan Insertable Cardiac Monitors (ICM) Market is segmented by indication into unexplained syncope, atrial fibrillation, cryptogenic stroke, palpitations, arrhythmia detection, bradycardia, tachycardia, other rhythm disorders. Among these, the Atrial Fibrillation dominated the market, accounting for nearly 41.8 in 2025 and expected to increase at a significant CAGR during the forecast period. With the increasing prevalence of atrial fibrillation worldwide, longer monitoring of heart rhythm is required, and thus a strong clinical need for continuous, highly accurate cardiac monitoring devices.

The Continuous Monitoring dominated the market, accounting for nearly 60.16 in 2025 and is expected to rise at a significant CAGR during the forecast period.

The Japan Insertable Cardiac Monitors (ICM) Market is segmented by technology into continuous monitoring, automatic arrhythmia detection, remote monitoring, wireless connectivity, ai-assisted detection, ecg recording, smartphone connectivity, cloud-based monitoring. Among these, the Continuous Monitoring dominated the market, accounting for nearly 60.16 in 2025 and expected to increase at a significant CAGR during the forecast period. Real-time, continuous cardiac monitoring translates into earlier detection of arrhythmias, more reliable diagnostics, and reduced dependency on periodic clinical testing.

Future Market Trends for the Japan Insertable Cardiac Monitors (ICM) Market: -

AI-Powered Diagnostics: Manufacturers are embedding artificial intelligence into ICM platforms to reduce false-positive alerts, enhance rhythm detection accuracy and optimize diagnostic workflow efficiency.
Expansion of Remote Patient Management Cardiologists can now easily monitor patient cardiac data in the outpatient and home-care setting with the growing use of cloud-connected, Bluetooth-enabled transmission systems.
Miniaturization and Ease of Use: Design improvements continue to reduce device size and simplify insertion procedures, greatly improving patient comfort and long-term adherence to monitoring.

Recent Development

1. In 2026, Biotronik is set to introduce the BIOMONITOR IV ICM with SmartECG artificial intelligence technology to the Japanese cardiac monitoring market, aiming to improve the capability to differentiate arrhythmias.
2. In 2025-2026, Abbott is continuing its rollout of the Assert-IQ ICM system in hospitals throughout Japan, with Bluetooth-enabled connectivity and multi-year battery life for remote cardiac care.
3. In 2025–2026, Medtronic to introduce Aurora EV-ICD extravascular defibrillator system in Japan, expanding its Reveal LINQ cardiac monitoring portfolio.
4. In 2026, Omron expands diagnostic cardiology footprint in Japan with acquisition of Heartnote Holter Monitoring, strengthening AI-based atrial fibrillation detection networks.

Market Segmentation

This study forecasts revenue at Japan, regional and country levels from 2020 to 2033. Transpire Insight has segmented the Japan Insertable Cardiac Monitors (ICM) Market based on the below-mentioned segments:

Japan Insertable Cardiac Monitors (ICM) Market, By Product Type

• Insertable Cardiac Monitors
• Implantable Loop Recorders
• Remote Monitoring Systems
• Patient-Activated Monitors
• Auto-Triggered Monitors
• MRI-Compatible ICMs
• Long-Term Monitoring Devices
• Connected ICMs

Japan Insertable Cardiac Monitors (ICM) Market, By Indication

• Unexplained Syncope
• Atrial Fibrillation
• Cryptogenic Stroke
• Palpitations
• Arrhythmia Detection
• Bradycardia
• Tachycardia
• Other Rhythm Disorders

Japan Insertable Cardiac Monitors (ICM) Market, By Technology

• Continuous Monitoring
• Automatic Arrhythmia Detection
• Remote Monitoring
• Wireless Connectivity
• AI-Assisted Detection
• ECG Recording
• Smartphone Connectivity
• Cloud-Based Monitoring

Japan Insertable Cardiac Monitors (ICM) Market, By Implant Location

• Left Chest
• Parasternal Region
• Subcutaneous Implantation
• Other Implant Sites
• Standard Implant Site
• Minimally Invasive Placement
• Local-Anesthesia Placement
• Outpatient Implantation

Japan Insertable Cardiac Monitors (ICM) Market, By End User

• Hospitals
• Cardiology Centers
• Electrophysiology Centers
• Specialty Clinics
• Academic Hospitals
• Ambulatory Centers
• Diagnostic Centers
• Research Institutes

Japan Insertable Cardiac Monitors (ICM) Market, By Patient Group

• Adults
• Elderly
• High-Risk Cardiac Patients
• Syncope Patients
• Stroke Patients
• AF Patients
• Arrhythmia Patients
• Other Cardiac Patients